Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Slides:

Advertisements

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Advertisements

Assessment of inflammation in noninfectious chronic maxillary sinusitis Pascal Demoly, MDa, Louis Crampette, MDb, Michel Mondain, MDb, Alison M. Campbell,

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome Paul Steinberg, MDa, Bruce E.

Kiwi fruit allergy: A new birch pollen–associated food allergy

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials Javier Dibildox,

A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis William R. Lumry, MD Journal of.

Kiwi fruit allergy: A new birch pollen–associated food allergy

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children Mark Boguniewicz, MDa, Virginia C. Fiedler,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials Javier Dibildox,

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

Edwin A. Bronsky, MD, Howard Druce, MD, Steven R. Findlay, MD, Frank C

Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis.

Product characteristics and pharmacokinetics of intranasal ipratropium bromide Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

Elinor Simons, MDa, William M

Elephantiasis nostras: A case report

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with.

Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol Henry Milgrom, MDa, David P. Skoner,

Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure Margherita Tomassini, MDa, Laura Magrini, MDa, Guido De.

Anaphylactic reaction to local administration of rifamycin SV

Practice Notes from the AAAAI

Allergic rhinoconjunctivitis caused by Harmonia axyridis (Asian lady beetle, Japanese lady beetle, or lady bug) John A. Yarbrough, MDa, Jack L. Armstrong,

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge Adriaan.

News & Notes Journal of Allergy and Clinical Immunology

James P. Kemp, MDa, David A. Cook, MDb, Gary A

Selective allergic reactions to clavulanic acid

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma William.

Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray Eli O. Meltzer,

Jack M. Becker, MDa, Anjali Arora, MDb, Richard J

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis Robert P. Harvey, MD, Carolyn Comer, MD, Barbara Sanders, MD, Ross Westley,

Thomas B. Casale, MDa, I. Leonard Bernstein, MDb, William W

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma Gordon D. Raphael, MDa, Robert.

News & Notes Journal of Allergy and Clinical Immunology

The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis Anjuli S. Nayak, MDa, Mark H.

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma Eugene R. Bleecker, MDa, Michael J. Welch, MDb,

Omalizumab improves asthma-related quality of life in patients with severe allergic asthma Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,

The 30th anniversary of the American Board of Allergy and Immunology: Then and now Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.

Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.

The role and remediation of animal allergens in allergic diseases

The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis Matthias Volkmar Kopp, MDa, Jens Brauburger,

Practice Notes from the AAAI

The natural progression of peanut allergy: Resolution and the possibility of recurrence David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa,

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma James P.

Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing.

Anaphylaxis after initial ingestion of rambutan, a tropical fruit

Terence J. Furlong, MSa, Jennifer DeSimonea, Scott H. Sicherer, MDb

Footnotes1 Journal of Allergy and Clinical Immunology

Larry C. Borish, MDa, Harold S

The environmental predictors of allergic disease

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial Eli O. Meltzer, MDa,

News & Notes Journal of Allergy and Clinical Immunology

Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal.

Presentation transcript:

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06% Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W. Georgitis, MDb, Jay Grossman, MDc, Paul H. Ratner, MDd, David G. Tinkelman, MD, Paul Roszko, RPhe, Elena Zegarelli, PhDe, Chester C. Wood, MDe Journal of Allergy and Clinical Immunology Volume 95, Issue 5, Pages 1128-1132 (May 1995) DOI: 10.1016/S0091-6749(95)70217-2 Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician assessments of the long-term efficacy of IB in treating PAR. Journal of Allergy and Clinical Immunology 1995 95, 1128-1132DOI: (10.1016/S0091-6749(95)70217-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician assessments of the long-term efficacy of IB in treating PAR. Journal of Allergy and Clinical Immunology 1995 95, 1128-1132DOI: (10.1016/S0091-6749(95)70217-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician assessments of the long-term efficacy of IB in treating PAR. Journal of Allergy and Clinical Immunology 1995 95, 1128-1132DOI: (10.1016/S0091-6749(95)70217-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician assessments of the long-term efficacy of IB in treating PAR. Journal of Allergy and Clinical Immunology 1995 95, 1128-1132DOI: (10.1016/S0091-6749(95)70217-2) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 2 Quality of life assessment after 1 year of therapy with IB for PAR. Journal of Allergy and Clinical Immunology 1995 95, 1128-1132DOI: (10.1016/S0091-6749(95)70217-2) Copyright © 1995 Mosby, Inc. Terms and Conditions